Wells Fargo & Company Oncology Institute, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.36 - $2.3 $5 - $9	4 Added 1.64%	248 $0
Q4 2023 Feb 09, 2024	BUY	$1.14 - $2.55 $17 - $38	15 Added 6.55%	244 $0
Q3 2023 Nov 13, 2023	BUY	$0.5 - $1.66 $22 - $73	44 Added 23.78%	229 $0
Q2 2023 Aug 15, 2023	SELL	$0.35 - $0.72 $2,335 - $4,804	-6,673 Reduced 97.3%	185 $0
Q1 2023 May 12, 2023	BUY	$0.48 - $1.7 $3,291 - $11,658	6,858 New	6,858 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.71 - $7.4 $69 - $725	98 Added 20.85%	568 $3,000
Q2 2022 Aug 12, 2022	BUY	$4.78 - $9.89 $1,940 - $4,015	406 Added 634.38%	470 $2,000
Q1 2022 May 16, 2022	BUY	$3.97 - $9.85 $254 - $630	64 New	64 $0

17.5M

Ticker TOI
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 73,495,504
Market Cap $11M
Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.